{"eligibility criteria":{"exclusion_criteria":[{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Prior <mark data-entity=\"procedure\">treatment</mark>with an <mark data-entity=\"drug\">anti-VEGF agent</mark><mark data-entity=\"temporal\">within 6 months</mark>of enrollment in this study ","ignore":false,"include":false,"logic_groups":[],"relations":[{"first":0,"second":2,"third":"has_temporal"},{"first":1,"second":2,"third":"has_temporal"}],"terms":[{"categorey":"Procedure","end_index":16,"neg":false,"start_index":7,"termId":0,"text":"treatment"},{"categorey":"Drug","end_index":40,"neg":false,"start_index":25,"termId":1,"text":"anti-VEGF agent"},{"categorey":"Temporal","end_index":56,"neg":false,"start_index":41,"termId":2,"text":"within 6 months"}],"text":" Prior treatment with an anti-VEGF agent within 6 months of enrollment in this study "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"observation\">Pregnancy</mark>( <mark data-entity=\"measurement\">positive pregnancy test</mark>) ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[{"categorey":"Observation","end_index":10,"neg":false,"start_index":1,"termId":0,"text":"Pregnancy"},{"categorey":"Measurement","end_index":36,"neg":false,"start_index":13,"termId":1,"text":"positive pregnancy test"}],"text":" Pregnancy ( positive pregnancy test ) "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Premenopausal <mark data-entity=\"demographic\">women</mark>not using adequate <mark data-entity=\"observation\">contraception</mark>. ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[{"categorey":"Demographic","end_index":20,"neg":false,"start_index":15,"termId":0,"text":"women"},{"categorey":"Observation","end_index":53,"neg":true,"start_index":40,"termId":1,"text":"contraception"}],"text":" Premenopausal women not using adequate contraception . "},{"display":" The following are considered effective means of <mark data-entity=\"observation\">contraception</mark>: <mark data-entity=\"procedure\">surgical sterilization</mark>or use of oral contraceptives , barrier <mark data-entity=\"observation\">contraception</mark>with either a condom or diaphragm in conjunction with spermicidal gel , an IUD , or <mark data-entity=\"condition\">contraceptive hormone implant</mark>or patch ","ignore":false,"include":false,"logic_groups":[[1],[],[3],[3]],"relations":[],"terms":[{"categorey":"Observation","end_index":62,"neg":false,"start_index":49,"termId":0,"text":"contraception"},{"categorey":"Procedure","end_index":87,"neg":false,"start_index":65,"termId":1,"text":"surgical sterilization"},{"categorey":"Condition","end_index":255,"neg":false,"start_index":226,"termId":3,"text":"contraceptive hormone implant"}],"text":" The following are considered effective means of contraception : surgical sterilization or use of oral contraceptives , barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel , an IUD , or contraceptive hormone implant or patch "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Prior enrollment in the study ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[],"text":" Prior enrollment in the study "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Any other <mark data-entity=\"condition\">condition</mark>that the investigator believes would pose a significant hazard to the subject if the <mark data-entity=\"drug\">investigational therapy</mark>were initiated ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[{"categorey":"Condition","end_index":20,"neg":false,"start_index":11,"termId":0,"text":"condition"},{"categorey":"Drug","end_index":129,"neg":false,"start_index":106,"termId":1,"text":"investigational therapy"}],"text":" Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Participation in another simultaneous medical investigation or trial ","ignore":false,"include":false,"logic_groups":[[]],"relations":[],"terms":[],"text":" Participation in another simultaneous medical investigation or trial "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Media insufficient to obtain a view ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[],"text":" Media insufficient to obtain a view "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"condition\">Other causes of CNV</mark><mark data-entity=\"negation_cue\">not</mark>related to <mark data-entity=\"condition\">AMD</mark>","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[{"categorey":"Condition","end_index":20,"neg":false,"start_index":1,"termId":0,"text":"Other causes of CNV"},{"categorey":"Condition","end_index":39,"neg":true,"start_index":36,"termId":2,"text":"Glycogen storage disease type II"}],"text":" Other causes of CNV not related to AMD "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"condition\">Active ocular</mark>or <mark data-entity=\"condition\">peri-ocular infection</mark>","ignore":false,"include":false,"logic_groups":[[1,0]],"relations":[],"terms":[{"categorey":"Condition","end_index":14,"neg":false,"start_index":1,"termId":0,"text":"Active ocular"},{"categorey":"Condition","end_index":39,"neg":false,"start_index":18,"termId":1,"text":"peri-ocular infection"}],"text":" Active ocular or peri-ocular infection "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"procedure\">Ocular surgery</mark><mark data-entity=\"temporal\">within 1 month</mark>prior to the study ","ignore":false,"include":false,"logic_groups":[],"relations":[{"first":0,"second":1,"third":"has_temporal"}],"terms":[{"categorey":"Procedure","end_index":15,"neg":false,"start_index":1,"termId":0,"text":"Ocular surgery"},{"categorey":"Temporal","end_index":30,"neg":false,"start_index":16,"termId":1,"text":"within 1 month"}],"text":" Ocular surgery within 1 month prior to the study "}]}],"inclusion_criteria":[{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Ability to provide written informed consent and comply with study assessments for the full duration of the study ","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[],"text":" Ability to provide written informed consent and comply with study assessments for the full duration of the study "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"demographic\">Age</mark><mark data-entity=\"value\">> 55 years</mark>","ignore":false,"include":false,"logic_groups":[],"relations":[{"first":0,"second":1,"third":"has_value"}],"terms":[{"categorey":"Demographic","end_index":4,"neg":false,"start_index":1,"termId":0,"text":"Age"},{"categorey":"Value","end_index":15,"neg":false,"start_index":5,"termId":1,"text":"> 55 years"}],"text":" Age > 55 years "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" Patients to be included in the study must have AMD with <mark data-entity=\"condition\">choroidal neovascularization</mark>","ignore":false,"include":false,"logic_groups":[],"relations":[],"terms":[{"categorey":"Condition","end_index":85,"neg":false,"start_index":57,"termId":0,"text":"choroidal neovascularization"}],"text":" Patients to be included in the study must have AMD with choroidal neovascularization "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"measurement\">BCVA</mark><mark data-entity=\"value\">between 20/20 - 20/400</mark>","ignore":false,"include":false,"logic_groups":[],"relations":[{"first":0,"second":1,"third":"has_value"}],"terms":[{"categorey":"Measurement","end_index":5,"neg":false,"start_index":1,"termId":0,"text":"Best corrected visual acuity"},{"categorey":"Value","end_index":28,"neg":false,"start_index":6,"termId":1,"text":"between 20/20 - 20/400"}],"text":" BCVA between 20/20 - 20/400 "}]},{"include":false,"pattern":0,"pid":0,"sents":[{"display":" <mark data-entity=\"condition\">Lesion</mark>size <mark data-entity=\"value\">less than or equal to 12 MPS disc</mark>areas ","ignore":false,"include":false,"logic_groups":[],"relations":[{"first":0,"second":1,"third":"has_value"}],"terms":[{"categorey":"Condition","end_index":7,"neg":false,"start_index":1,"termId":0,"text":"Lesion"},{"categorey":"Value","end_index":46,"neg":false,"start_index":13,"termId":1,"text":"less than or equal to 12 MPS disc"}],"text":" Lesion size less than or equal to 12 MPS disc areas "}]}],"initial_event":[],"initial_event_constraint":{"daysAfter":0,"daysBefore":0,"limitTo":"All"}}}